The Selfish Brain Clinical Research Group 
Original Papers since 2000 :
Andreas Moser, Professor of Neurology and Neurochemistry
Clinic of Neurology, University of Luebeck, Germany

  1. Neusch C, Böhme V, Riesland N, Althaus M, Moser A, 2000 The dopamine D2 receptor agonist alpha-dihydroergocryptine modulates voltage-gated sodium channels in the rat caudate-putamen. J Neural Transm 107, 531-541

  2. Neusch C, Runde D, Moser A, 2000 G-proteins modulate D2 receptor-coupled K(ATP) channels in rat dopaminergic terminals. Neurochem Res 25, 1521-1526

  3. Thümen A, Behnecke A, Qadri F, Bäuml E, Moser A, 2002 N-Methyl-Norsalsolinol, a putative dopaminergic neurotoxin, passes through the blood-brain barrier in vivo. Neuroreport 13, 25-28

  4. Bringmann G, Feineis D, God R, Peters K, Peters EM, Scholz J, Riederer F, Moser A, 2002 1-Trichloromethyl-1,2,3,4-tetrahydro-ß-carboline (TACLO) and related derivatives: Chemistry and biochemical effects on catecholamine biosynthesis. Bioorganic & Medicinal Chemistry 10, 2207-2214

  5. Riederer F, Luborzewski A, God R, Bringmann G, Scholz J, Feineis D, Moser A, 2002 Modification of tyrosine hydroxylase activity by chloral derived b-carbolines in vitro. J Neurochem 81, 814-819

  6. Thümen A, Albrecht P, Dodt Ch, Moser A, 2002 Neuroleptospirose: Eine vergessene Erkrankung. Aktuelle Neurologie 29, 409-413

  7. Thümen A, Qadri F, Sarkar R, Moser A, 2002 GBR-12909 effect on dopamine outflow depends on phosphorylation in the caudate nucleus of the rat. Synapse 46, 72-78

  8. Thümen A, Behnecke A, Qadri F, Moser A, 2003 N-Methyl-Norsalsolinol modulates serotonin metabolism in the rat caudate nucleus: correlation with behavioral changes. Int J Neuropsychopharmacology 6, 35-40

  9. Maass A, Scholz J, Moser A, 2003 Modelled ligand-protein complexes elucidate the origin of substrate specificity and provide insight into catalytic mechanisms of phenylalanine hydroxylase and tyrosine hydroxylase. Eur J Biochem 270, 1065-1075

  10. Moser A, Gieselberg A, Ro B, Keller Ch, Qadri F, 2003 Deep brain stimulation: response to neuronal high frequency stimulation is mediated through GABAA receptor activation in rats. Neuroscience Letters 341, 57-60

  11. Moser A, Hagenah J, Kömpf D, 2003 Halluzinationen beim M. Parkinson. Der Nervenarzt 74, 376-386

  12. Moser A, Thümen A, Qadri F, 2003 Modulation of striatal serotonin and opioid receptor mRNA expression following systemic N-methyl-norsalsolinol administration. J Neurol Sci 216, 107-110

  13. Scholz J, Klingemann I, Moser A, 2004 Increased systemic levels of norsalsolinol derivatives are induced by levodopa treatment and do not represent biological markers of Parkinson’s disease. J Neurol Neurosurg Psychiat 75, 634-636

  14. Li TL, Qadri F, Moser A, 2004 Neuronal electrical high frequency stimulation modulates presynaptic GABAergic physiology. Neuroscience Letters 371, 117-121